SOPHARMA AD: DISCLOSURE OF SHAREHOLDINGS

opublikowano: 2012-04-18 16:05

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_32_d_uchastie_Gramercy_18042012_ЕNG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 32 / 2012
Date of issue: 2012-04-18
Short name of the issuer
SOPHARMA AD
Subject
DISCLOSURE OF SHAREHOLDINGS
Official market - legal basis
Inne uregulowania
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") announces that it has received notifications of disclosure of shareholdings under Art. 145 of POSA:

Gramercy Select Master Fund, USA, Georgetown sold 8,587,285 shares, representing 6.51% of the capital of Sopharma, thereby closing its position in the capital of "Sopharma" AD, and
Gramercy Emerging Markets Fund, USA, Georgetown sold 7,980,192 shares, representing 6.05% of the capital of Sopharma, thereby closing its position in the capital of "Sopharma" AD.

The date of registration of the two transactions with the Central Depository is April 9, 2012.
Annexes
File Description

Current report 32 d_uchastie_Gramercy_18042012 ЕNG.doc Current report 32 d_uchastie_Gramercy_18042012 ЕNG.doc 		Current report 32

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-04-18 Ognian Ivanov Donev Executive Director